Building transformative technologies to facilitate, improve, and enhance human thriving.
UC San Diego Alum Leads Company Behind First FDA Approved At-Home COVID Test
In November 2020, Lucira Health received emergency use authorization for the first rapid at-home COVID-19 test from the U.S. Food and Drug Administration. Erik Engelson, a UC San Diego bioengineering and microbiology alumnus, is president and CEO of Lucira Health.
David Bresllauer, '05 PhD
CSO and Co-Founder at Bolt ThreadsHow Bioengineering Could Bring Greater Sustainability to the Apparel Industry
The idea that one day the clothes you wear will be made from spider silk, or maybe even mushrooms, might sound very… Californian. You know, a little over-the-top earthy and too good to be true.
For David Breslauer ’05, the co-founder and chief scientific officer at Bolt Threads, a bioengineering company in Emeryville, Calif., the potential of the spider and the mushroom represent not just another way to make apparel, but a way to bring greater sustainability to the clothing industry.
Forbes 30 Under 30 2020
From Forbes 30 Under 30 Profile:
With a background in life sciences technology development, unmet clinical needs discovery, and biotechnology entrepreneurship, Joshua Yang invents and commercializes biomedical technologies that he can translate into clinical practice. He also works to identify promising biotech and healthcare innovations and startups for investment opportunities.
Yang co founded kidney diagnostics startup Nephrosant, which is based on his research into kidney injury prediction. The company is developing non-invasive tools to measure kidney injuries. Yang also is active in venture capital, performing due diligence and sourcing for Pear Ventures and SeaX ventures on healthcare deals.
Co-founder and CEO of Glyphic Biotechnologies, a VC-funded biotechnology startup commercializing a next-generation protein sequencing platform. My first startup Nephrosant has raised over $22M in funding to commercialize a low-cost, non-invasive diagnostic assay for kidney injury.
Double majored in Bioengineering: Biotechnology B.S. and General Biology B.S where I was a Barry Goldwater Scholar and the Valedictorian in Bioengineering. Subsequently, I completed a Master of Translational Medicine degree through the University of California, San Francisco and University of California, Berkeley in the Department of Bioengineering. I am currently on leave of absence from the MSTP MD-PhD at the Johns Hopkins University School of Medicine and Department of Biomedical Engineering. I graduated with an MBA from the Stanford University Graduate School of Business, where I was the Henry Ford II Scholar (Valedictorian), Siebel Scholar, and Arjay Miller Scholar.
Joshua Yang, PhD '15
Co-Founder and CEO, Glyphic BiotechnologiesWe celebrate the women who are dismantling social constructs, systemic barriers & unrealistic ideals holding us back from thriving at our limitless potential.
Monica Mo is a bioengineer and biotech scientist now in her second act as a mental health advocate, wellness media entrepreneur, and speaker, dedicated to exploring our culture’s influence on our physical & mental wellbeing and championing the women who challenge the status quo to redefine health & happiness.
Monica Mo '04, PhD '09
Founder & CEO , Well SeekDeep thinking training through research and experimentation.
Wande Zhang took his analytical problem-solving skill set from UC San Diego and has applied it to the finance industry, working for Bank of America. He feels that the analytical skill set has been key to his success as well as deep thinking training through research and experimentation.
